Semen Analysis After Proton Therapy for Prostate Cancer
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Other: Semen analysis
- Registration Number
- NCT01072513
- Lead Sponsor
- University of Florida
- Brief Summary
The purpose of this study is to evaluate semen for changes following treatment with proton radiation therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 31
Inclusion Criteria
- Diagnosis of low to intermediate risk prostate cancer and elected to have proton radiation therapy at University of Florida Proton Therapy Institute (UFPTI).
Exclusion Criteria
- Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo.
- History of vasectomy.
- Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin.
- Current use of Avodart or Proscar.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Semen analysis Semen analysis Analysis of semen before and after proton radiation therapy.
- Primary Outcome Measures
Name Time Method Post treatment sperm count 12 months after radiation therapy
- Secondary Outcome Measures
Name Time Method Compare changes in sperm motility, sperm morphology and semen PH. 12 months after radiation therapy This is composite measure
Trial Locations
- Locations (1)
University of Florida Proton Therapy Institute
🇺🇸Jacksonville, Florida, United States